DUPONT ACA VANCOMYCIN (VANC) METHOD— 510(k) K945125
Substantially EquivalentThe DU Pont Co.
FDA 510(k) clearance K945125 for DUPONT ACA VANCOMYCIN (VANC) METHOD, Substantially Equivalent on 1995-03-10. Applicant: The DU Pont Co.. Device class: 2.
Clearance details
- Applicant
- The DU Pont Co.
- Product code
- Code LEH
- Device class
- Class 2
- Regulation
- 21 CFR 862.3950
- Advisory panel
- Clinical Toxicology
- Date received
- Decision date
- Decision
- Substantially Equivalent
- Clearance type
- Traditional
- Location
- Wilimington, DE, US
Recent devices under product code LEH
view all- K222439 — Atellica® CH Phencyclidine (Pcp), Atellica® CH Vancomycin (Vanc)
- K160202 — Trinidad CH Vancomycin (Vanc), Trinidad CH Drug 3 Calibrator (DRUG3 CAL)
- K152245 — ONLINE TDM Vancomycin Gen.3
- K123947 — ARCHITECT IVANCOMYCIN
- K072036 — ARCHITECT IVANCOMYCIN REAGENTS AND ARCHITECT IVANCOMYCIN CALIBRATORS, MODELS: 1P30-25 AND 1P30-01
More clearances from The DU Pont Co.
view allData sourced from openFDA. This site is unofficial and independent of the FDA.